Ann: Annual Report to shareholders, page-53

this is now what many here have mentioned over the course of this year, EPT can now move from being that speculative stock that people can trade short term and have volatility to those who want to park larger sums of money into for a growth strategy from speculative to revenue generating mid cap company which will one day make the ASX300 and even 200 index, which then attracts further buying from index funds who replicate the index or are bound by their in house rules to only buying shares in the those indices.

This attention of funds via the likes of Insidemarket which itself is a fund is great!! and i like the question of is it the next cochlear or resmed. just think there was a time when those companies were once speculative in nature too!!!

philip daffas would have a good insight of comparing companies as stated he once was the VP of Marketing at Cochlear Global Marketing Manage Roche.